INSIGHTS ON DRUG DEVELOPMENT

• Accelerated Yield Optimization Of Affinity Capture

  High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes.

• Design Scalable Downstream Processes With Practical Strategies

  Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.

• Faster Clones, Simpler Process: What's Changing In CHO Expression?

  This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.

• How Adept Formulation Helps Overcome Manufacturability Challenges

  Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.

• Spray Dried Dispersions In Controlled Release Formulations

  10/16/2025

  Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation.

• Advancing GLP-1 Analog Drug Development Using A Variety Of Techniques

  6/27/2025

  Discover how SEC-MALS reveals the aggregation behavior of GLP-1 analogs like semaglutide and liraglutide, which are critical for ensuring the stability, efficacy, and safety of peptide therapeutics.

• Predicting Softgel Stability And Shelf Life Using Accelerated Modeling

  7/15/2026

  Predict ibuprofen softgel shelf life in 21 days instead of years. ASAPprime modeling identified PEG-ester degradants as the limiting factor, estimating 5.5-year and 3.8-year shelf lives before long-term studies concluded.

• Bridging Development And Manufacturing For Better Outcomes

  8/31/2026

  Learn how integrated formulation, analytical, and manufacturing strategies help overcome development challenges and advance drug candidates from early stages to commercialization.

• De-Risking Drug Development: Informatics-Supported Solid Form Selection

  5/6/2026

  Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.